TBI Overview2020-02-26T19:50:32+00:00

News

NCAA Collegiate Sports Leader Gene DeFilippo and Head Lacrosse Coach at University of Virginia, Lars Tiffany, Join BioDirection Sports Advisory Board

Managing Director of Turnkey Sports and Former Boston College Athletic Director Along with UVA Head Coach Bring Invaluable Sports Expertise to Critical Concussion Protocol Discussion.

Boston, MA Jan 10, 2018 — BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of concussions and other acquired traumatic brain injuries, today announced the appointment of Gene DeFilippo and Lars Tiffany to the company’s Sports Advisory Board.

“As chairman of the BioDirection Sports Advisory Board, I am very pleased to have Gene and Lars bring their expertise in the field of athletics to the company’s development efforts. Their decades of experience in the front office and on the sidelines of some of the country’s most prestigious Division 1 institutions will provide invaluable guidance, insight and direction to the company as we develop strategies for launching our Tbit™ System in university, inter-scholastic and youth athletic programs,” said Stephen Brackett, director of BioDirection, Inc.

Mr. DeFilippo is an American sports executive and former college athletics administrator. He is currently managing director at Turnkey Sports and Entertainment and a member of the Board of the National Football Foundation. Mr. DeFilippo served as the athletic director at the University of South Carolina–Spartanburg—now known as the University of South Carolina Upstate—from 1984 to 1987, at Villanova University from 1993 to 1997, and at Boston College from 1997 to 2012.

“The safety of athletes is vitally important to all of us,” stated Mr. DeFilippo. “Concussions are happening on every college and university campus at both the intramural and inter-collegiate level. Coaches, trainers and physicians are desperately searching for definitive testing solutions to rapidly confirm a diagnosis of concussion, and I am committed to advancing BioDirection’s effort to bring those solutions to all athletic settings.”

Mr. Tiffany is currently head lacrosse coach at the University of Virginia (UVA). Prior to moving to UVA in 2016, he was head coach at Brown University where he served for 10 seasons. A 1990 graduate of Brown University, he was a two-time lacrosse captain and a defensive standout for three years. Mr. Tiffany began his college coaching career at LeMoyne College followed by assistant coaching positions at Washington & Lee, Dartmouth and Penn State. He was later named head coach at Stony Brook before moving to Brown in 2007. Mr. Tiffany is known for his passion for development of young men as student-athletes, and has earned national recognition as an innovative coach and leader.

Mr. Tiffany stated, “Uncertainty and guesswork abounds when it comes to diagnosing concussions. It is shocking to have a branch of medicine in the 21st century that is so subjective and non-conclusive. We need a field-side objective test that will allow us to protect our athletes from further injury.”

The Tbit System uses a patented nanotechnology biosensor to rapidly detect and accurately measure protein biomarkers that are released from the brain immediately following a head trauma. The portable system allows for testing to be performed at the initial stages of medical diagnosis and intervention. Earlier diagnosis of a concussion can support more appropriate treatment decisions while reducing unnecessary head CT scans.

About NanoDx, Inc.

NanoDx, Inc., is a privately held medical device company developing breakthrough, point-of-care diagnostic solutions that address unmet market needs and improve patient outcomes while reducing healthcare costs. The company's flagship product, the NanoDx System, is capable of detecting and quantifying biomarkers (analytes) from a small fluid specimen in less than 2 minutes. NanoDx's platform utilizes a proprietary nanosensor technology with a broad range of potential diagnostic applications including COVID-19, Traumatic Brain Injury (TBI), Influenza, Sepsis and Stroke. www.NanoDiagnostics.com

Contacts
Mike Sampson
Chief Commercial Officer
Tel: +1 508.599.2400
Email: msampson@nanodiagnostics.com